Literature DB >> 19330270

Rosacea and its topical management.

M Gooderham.   

Abstract

Many options exist for the treatment of rosacea, including topical and systemic therapies, laser and light-based therapies, and surgical procedures. A classification system for rosacea identifies 4 subtypes (i.e., erythematotelangiectatic, papulopustular, phymatous, and ocular), which may help guide therapeutic decision-making. The goals of therapy include reduction of papules, pustules, erythema, physical discomfort, and an improvement in quality of life. Standard topical treatment agents include metronidazole, azelaic acid, and sodium sulfacetamide-sulfur. Second line therapies include benzoyl peroxide, clindamycin, calcineurin inhibitors, and permethrin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330270

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN: 1201-5989


  2 in total

1.  Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice.

Authors:  Dmitry Litvinov; Krithika Selvarajan; Mahdi Garelnabi; Larissa Brophy; Sampath Parthasarathy
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

2.  A Novel Mechanism for Atherosclerotic Calcification: Potential Resolution of the Oxidation Paradox.

Authors:  Aladdin Riad; Chandrakala Aluganti Narasimhulu; Pragney Deme; Sampath Parthasarathy
Journal:  Antioxid Redox Signal       Date:  2018-01-24       Impact factor: 8.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.